CA2271935A1 - Modulation d'interactions entre myosine et integrines - Google Patents

Modulation d'interactions entre myosine et integrines Download PDF

Info

Publication number
CA2271935A1
CA2271935A1 CA002271935A CA2271935A CA2271935A1 CA 2271935 A1 CA2271935 A1 CA 2271935A1 CA 002271935 A CA002271935 A CA 002271935A CA 2271935 A CA2271935 A CA 2271935A CA 2271935 A1 CA2271935 A1 CA 2271935A1
Authority
CA
Canada
Prior art keywords
integrin
myosin
peptide
agent
beta
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002271935A
Other languages
English (en)
Inventor
Alison L. Jenkins
David R. Phillips
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Millennium Pharmaceuticals Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority claimed from PCT/US1997/022422 external-priority patent/WO1998022500A2/fr
Publication of CA2271935A1 publication Critical patent/CA2271935A1/fr
Abandoned legal-status Critical Current

Links

Landscapes

  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La présente invention décrit une interaction directe entre la myosine et le domaine cytoplasmique de protéines membranaires, en particulier les domaines cytoplasmiques phosphorylés de la sous-unité .beta. d'intégrines. L'invention concerne des méthodes d'identification d'agents bloquant la liaison d'intégrine à la myosine; des méthodes d'utilisation d'agents bloquant la liaison d'intégrine à la myosine afin de moduler des procédés biologiques et pathologiques; et des agents bloquant la liaison assistée d'intégrine à la myosine, modulant ainsi le déplacement associé d'une cellule ou d'un composant cellulaire.
CA002271935A 1996-11-21 1997-11-21 Modulation d'interactions entre myosine et integrines Abandoned CA2271935A1 (fr)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US3166596P 1996-11-21 1996-11-21
US60/031,665 1996-11-21
US4209397P 1997-03-28 1997-03-28
US60/042,093 1997-03-28
US97565397P 1997-11-21 1997-11-21
PCT/US1997/022422 WO1998022500A2 (fr) 1996-11-21 1997-11-21 Modulation d'interactions entre myosine et integrines
US60/975,653 1997-11-21

Publications (1)

Publication Number Publication Date
CA2271935A1 true CA2271935A1 (fr) 1998-05-28

Family

ID=29715947

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002271935A Abandoned CA2271935A1 (fr) 1996-11-21 1997-11-21 Modulation d'interactions entre myosine et integrines

Country Status (1)

Country Link
CA (1) CA2271935A1 (fr)

Similar Documents

Publication Publication Date Title
KR101516023B1 (ko) 눈물 리포칼린 돌연변이 단백질 및 이를 얻는 방법
RU2569745C2 (ru) Мутеины липокалина слезы, связывающие альфа il-4 r
US9260492B2 (en) Muteins of human lipocalin 2 with affinity for glypican-3 (GPC-3)
US7718615B2 (en) Contortrostatin (CN) and methods for its use in preventing metastasis and other conditions
CA2331239A1 (fr) Structure, fabrication et utilisation de l'hereguline
JP2008109934A (ja) ウロキナーゼレセプターのペプチドリガンド
JP2017035091A (ja) 促進されたプロセシングを備えた修飾された酸性アルファグルコシダーゼ
EP1833964A1 (fr) Régulation du clivage par des métalloprotéases de protéines de surface d'une cellule
TW202212350A (zh) 補體因子i相關組合物及方法
BG107214A (bg) Пептид, модулиращ тромбопоетиновия рецептор
KR102047235B1 (ko) 단작용성 인자 vii 폴리펩티드
JP2022522566A (ja) CHO細胞で発現されたhet IL-15
CN101516907A (zh) 泪液脂质运载蛋白的突变蛋白及其获得方法
WO1997035969A9 (fr) Ligands peptidiques du recepteur de l'urokinase
NZ335932A (en) Use of a peptide agent such as a diphosphorylated peptide to modulate the interactions between myosin and integrins
WO1998022500A9 (fr) Modulation d'interactions entre myosine et integrines
NZ293261A (en) Recombinant pallidipin protein, asp-pallidipin, which inhibits collagen induced platelet aggregation inhibitor
US20180216094A1 (en) REVERSAL AGENTS FOR FXIa INHIBITORS
CA2271935A1 (fr) Modulation d'interactions entre myosine et integrines
US6794358B1 (en) Peptide ligands of the urokinase receptor
AU3822602A (en) Modulation of interactions between myosin and integrins
US11072643B2 (en) Fusion protein
US20030186884A1 (en) Contortrostatin (CN) and methods for its use in preventing metastasis and other conditions
EP0642354A1 (fr) PROCEDES PERMETTANT DE DETECTER ET D'ISOLER L'uPA-R ET D'INHIBER LA LIAISON DE L'uPA A L'uPA-R
US20050074754A1 (en) Novel protein and use thereof

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued